AbbVie Inc. (ABBV) Stock

About AbbVie Inc.

AbbVie Inc. is led by CEO Robert A. Michael, employs 55,000 people, headquartered in North Chicago, US, publicly traded since 2013.

AbbVie Inc. (ABBV) stock trades at $285.42 with a market capitalization of $504.37B. The stock is valued at a price-to-earnings (P/E) ratio of 79.88, a negative price-to-book of -84.60, reflecting negative shareholders' equity, price-to-sales of 7.78. Over the past 52 weeks the stock has ranged between $190.75 and $289.65, and currently trades 1.5% below its 52-week high. It pays a dividend yielding 2.44%.

On profitability, AbbVie Inc. generates a return on equity (ROE) of -136.50% (not meaningful, as shareholders' equity is negative), return on capital employed of 20.19%, an operating margin of 32.85%, a net profit margin of 9.81%.

In its most recent fiscal year, AbbVie Inc. reported annual revenue of $61.2B, net profit of $4.2B. Over the last 5 fiscal years, revenue grew at an average annual rate of 6.0%, and net profit declined at an average annual rate of 1.7%.

The balance sheet shows a debt-to-equity ratio of -11.93 (negative because shareholders' equity is negative), a current ratio of 0.67, total assets of $134.0B, $5.2B in cash and equivalents.

ABBV has an average daily trading volume of 5,918,150 shares, a beta of 0.28 (historically less volatile than the overall market).